You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華億金控(08123.HK)附屬擬950萬元出售南瑞生物科技集團(深圳)30%股權
格隆匯 12-24 17:03

格隆匯12月24日丨華億金控(08123.HK)公告,於2020年12月24日,賣方深圳國銀盛世貴金屬經營有限公司(公司間接非全資附屬公司)與買方深圳廣達世聯科技發展有限公司訂立股份轉讓協議,賣方同意向買方出售目標公司南瑞生物科技集團(深圳)有限公司30%股權,代價為現金人民幣950萬元。

於2019年一月或前後,目標公司一直進行有關於中國成立一所生物醫學實驗室的項目。於中國成立實驗室須獲得中國政府批准,而目標集團自2019年一月起一直進行該計劃。於2020年第三季度或前後,公司管理層意識到,取得該計劃的批准需時,因為其涉及授予土地使用權及有關於中國成立生物醫學實驗室的其他必要批准。

董事已評估目標集團的業務發展潛力,並認為該計劃實現的時間變得不確定,且出售事項為集團提供機會變現其於銷售股份的投資並賺取溢利,並可改善集團的流動資金以迎接其他更具增長潛力的新的合適投資機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account